Published in Cancer Weekly, May 1st, 1995
Steven M. Dubinett et al. suggest that IL-7 can be used as a cytokine for the in vitro expansion of lymphocytes for adoptive transfer and as an immunotherapeutic systemic agent against cancer, ("Down-Regulation of Murine Fibrosarcoma Transforming Growth Factor-(beta)1 Expression by Interleukin-7," Journal of the National Cancer Institute, April 19, 1995;87(8):593-97).
According to the authors, IL-7 has several important immunoregulatory properties. IL-7 can...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.